Support Tool Could Aid Decision on Total Joint Arthroplasty

This article originally appeared here.
Share this content:
Support Tool Could Aid Decision on Total Joint Arthroplasty
Support Tool Could Aid Decision on Total Joint Arthroplasty

WEDNESDAY, Sept. 16, 2015 (HealthDay News) -- A decision-support tool would help with decision making for total joint arthroplasty (TJA) for patients with osteoarthritis, according to a study published online Sept. 8 in the Journal of Evaluation in Clinical Practice.

Lucy Frankel, from Women's College Hospital in Toronto, and colleagues conducted semi-structured telephone interviews of orthopedic surgeons in three Canadian provinces to determine surgeons' criteria for TJA appropriateness for osteoarthritis.

The researchers found, based on the responses of 14 of 17 approached participants (12 males; five academic), that pain and pain impact on patients' quality of life and function were the key criteria to assess appropriateness for TJA. However, the respondents acknowledged that these factors are difficult to assess and not always tied to structural changes on joint radiography. Patient age may affect appropriateness, the surgeons said. Most of the surgeons agreed that a decision-support tool would aid standardization of assessment, but they said the ultimate decision must be left to the discretion of surgeons, within the context of the doctor-patient relationship.

"Surgeons recognized the need for a tool to support decision making for TJA, particularly in the context of increasing surgical demand in younger patients with less severe arthritis," write the authors.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »